or Try an Advanced Search...

    Technical Analysis for BWAY - Brainsway Ltd.

    Grade Last Price % Change Price Change
    C 6.58 4.61% 0.29
    BWAY closed down 4.12 percent on Friday, May 31, 2024, on 1.83 times normal volume.
    Earnings due: Jun 17
    *** please verify all earnings dates ***
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Up Up
    Historical BWAY trend table...
    Date Alert Name Type % Chg
    Wide Range Bar Range Expansion 4.61%
    Upper Bollinger Band Walk Strength 4.61%
    Above Upper BB Strength 4.61%
    Gapped Up Strength 4.61%
    Upper Bollinger Band Touch Strength 4.61%
    Expansion Breakout Bullish Swing Setup 0.30%
    Expansion Pivot Buy Setup Bullish Swing Setup 0.30%
    Pocket Pivot Bullish Swing Setup 0.30%
    Volume Surge Other 0.30%
    Wide Range Bar Range Expansion 0.30%
    Older End-of-Day Signals for BWAY ...

       Recent Intraday Alerts

    Alert Time
    2x Volume Pace about 1 hour ago
    1.5x Volume Pace about 1 hour ago
    Up 5% about 1 hour ago
    Up 3% about 1 hour ago
    Up 2% about 1 hour ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    BWAY Chart by TradingView
    Basic chart:

    Profile

    Brainsway is a commercial stage medical device company focused on the development and sale of non-invasive neuromodulation products using the Company’s proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) technology for the treatment of major depressive disorder (MDD) and obsessive-compulsive disorder (OCD), for which Brainsway received marketing authorization from the U.S. Food and Drug Administration (FDA) in 2013 (for MDD) and in August 2018 (for OCD). Brainsway is currently conducting clinical trials of Deep TMS in other psychiatric, neurological and addiction disorders, including smoking cessation and post-traumatic stress disorder, and is planning trials for opioid addiction, fatigue in multiple sclerosis (MS) and post-stroke rehabilitation.
    Classification
    Sector: Healthcare
    Industry: Diagnostics & Research
    Keywords: Neuroscience FDA Mental Health Opioids Stroke Multiple Sclerosis Psychiatry Major Depressive Disorder Neuromodulation Neurophysiology Depressive Disorder Smoking Neurotechnology Neuropsychology Post Traumatic Stress Disorder Smoking Cessation Treatment Of Major Depressive Disorder Obsessive Compulsive Disorder Addiction Neuromodulation Products Treatment Of Depression Non Invasive Neuromodulation Products

    Is BWAY a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 2 bullish, 0 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 13 Wall Street Analysts Believe Brainsway (BWAY) Could Rally 120.45%: Here's is How to Trade
    Apr 24 BrainsWay to Report First Quarter 2024 Financial Results on May 8, 2024
    Apr 4 BrainsWay Announces Published Review Results Highlighting Potential of Deep TMS™ to Treat Parkinson's Disease
    Mar 27 After Plunging -13.63% in 4 Weeks, Here's Why the Trend Might Reverse for Brainsway (BWAY)
    Mar 18 All You Need to Know About Brainsway Ltd. Sponsored ADR (BWAY) Rating Upgrade to Buy
    Mar 18 BrainsWay Broadens Partnership with Katie’s Way Plus Through Order of an Additional 18 Deep TMS™ Systems
    Mar 7 BrainsWay: Profitable, Growing, And Cheap
    Mar 6 BrainsWay Ltd. (BWAY) Q4 2023 Earnings Call Transcript
    Mar 6 Brainsway beats top-line and bottom-line estimates; initiates FY24 outlook
    Mar 6 BrainsWay Reports Fourth Quarter and Full-Year 2023 Financial Results and Operational Highlights
    See more BWAY news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 7.615
    52 Week Low 1.75
    Average Volume 68,156
    200-Day Moving Average 5.20
    50-Day Moving Average 5.40
    20-Day Moving Average 5.61
    10-Day Moving Average 5.64
    Average True Range 0.39
    RSI (14) 64.29
    ADX 15.01
    +DI 33.49
    -DI 12.11
    Chandelier Exit (Long, 3 ATRs) 5.70
    Chandelier Exit (Short, 3 ATRs) 6.31
    Upper Bollinger Bands 6.27
    Lower Bollinger Band 4.95
    Percent B (%b) 1.01
    BandWidth 23.52
    MACD Line 0.15
    MACD Signal Line 0.06
    MACD Histogram 0.0938
    Fundamentals Value
    Market Cap 104.55 Million
    Num Shares 16.6 Million
    EPS -0.48
    Price-to-Earnings (P/E) Ratio -13.10
    Price-to-Sales 3.45
    Price-to-Book 2.44
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 7.62
    Resistance 3 (R3) 7.67 7.28 7.40
    Resistance 2 (R2) 7.28 6.94 7.26 7.33
    Resistance 1 (R1) 6.79 6.73 6.59 6.73 7.25
    Pivot Point 6.39 6.39 6.29 6.37 6.39
    Support 1 (S1) 5.90 6.05 5.70 5.85 5.33
    Support 2 (S2) 5.50 5.84 5.48 5.25
    Support 3 (S3) 5.01 5.50 5.18
    Support 4 (S4) 4.96